Non-Hodgkin lymphoma (NHL) is a blood cancer that develops in the lymphatic system. It usually starts in the lymphocytes, which are a type of white blood cell, and because lymphocytes are all over the body, it can grow in other parts of the body as it travels through the blood and lymphatic system.
The World Health Organization has identified more than 60 different subtypes of NHL. Most are classified as B-cell lymphomas or T-cell lymphomas depending on what type of cell they affect. The most common types of NHL are diffuse large B-cell lymphoma and follicular lymphoma. For both of these, survival rates are high.
There are many treatments available for NHL, including chemotherapy, radiation, immunotherapy and targeted therapy. Because non-Hodgkin lymphoma is one of the most common cancers in the United States, options for support and treatment are numerous and improving on a consistent basis.
To learn more about non-Hodgkin lymphoma, navigate to "What is Non-Hodgkin Lymphoma?"